TABLE 1.
The changes and functions of gut microbiota in CKD state.
| Bacteria | Changes | Key functions | References |
| Firmicutes | |||
| Lactobacillus | Decrease | Reverse inflammation and prevent the progression of kidney damage; protect CVD. | Yoshifuji et al. (2016), Xu et al. (2019) |
| Ruminococcaceae | Decrease | The production of butyrate has a protective effect on CKD and CVD | Jiang et al. (2017), Ahrens et al. (2021) |
| Enterococcus | Increase | Positively correlated with TMAO levels, and may serve as a biomarker of CVD. | Jiang et al, (2017), Xu et al. (2017), Liu et al. (2019) |
| Actinobacteria | |||
| Bifidobacterium | Decrease | Promote colon health and produce SCFAs, delaying CKD progression. | Ranganathan et al. (2009), Vaziri et al. (2013a), Wang et al. (2020a) |
| Eggerthella lenta | Increase | Increase uremic toxins production and promote renal disease development in a CKD rat model. | Wang et al. (2020a) |
| Bacteroidetes | |||
| Bacteroides | Decrease | Prevent CVD by reducing fecal LPS levels and suppressing immune response. | Vaziri et al. (2013a), Yang et al. (2018), Yoshida et al. (2020) |
| Prevotella | Decrease | Improve intestinal environment, thereby alleviating the progression of CKD and the accumulation of uremic toxins. | Mishima et al. (2015), Jiang et al. (2017), Xu et al. (2017) |
| Proteobacteria | |||
| Escherichia coli | Increase | Convert tryptophan into indole by tryptophanase, and then into IS, aggravating CKD, CVD and intestinal injury. | Devlin et al. (2016), Jin et al. (2019), Huang et al. (2020b) |
| Verrucomicrobia | |||
| Akkermansia | Decrease | Protect intestinal mucosa; negatively correlated with the progression of CKD and CVD. | Li et al. (2019), Wang et al. (2020b) |